Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
2012
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Artificial intelligence in healthcare: past, present and future
2017 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Telavancin: A Novel Lipoglycopeptide
2009
Central Challenges Facing the National Clinical Research Enterprise
2003
The Impact of ICD-9-CM Code Rank Order on the Estimated Prevalence of Clostridium difficile Infections
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Natural products: A continuing source of novel drug leads
2013 Standout
Urinary Tract Infection in Male Veterans
2012
Clostridium difficileInfections among Hospitalized Children, United States, 1997–2006
2010
Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008
2012
Impact of a Prospective-Audit-With-Feedback Antimicrobial Stewardship Program at a Children's Hospital
2012
The REDCap consortium: Building an international community of software platform partners
2019 Standout
Hand Hygiene, and Not Ertapenem Use, Contributed to Reduction of Carbapenem-Resistant Pseudomonas aeruginosa Rates
2011
The Meaning of Translational Research and Why It Matters
2008 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
2014 Standout
Implementation Research in Mental Health Services: an Emerging Science with Conceptual, Methodological, and Training challenges
2008 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
2011 Standout
Benchmarking antimicrobial drug use in hospitals
2012
Audit and Feedback to Reduce Broad-Spectrum Antibiotic Use among Intensive Care Unit Patients A Controlled Interrupted Time Series Analysis
2012
Antimicrobial resistance: a global multifaceted phenomenon
2015 Standout
Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study
2012
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection
2015
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
2011
Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features
2019
Mining peripheral arterial disease cases from narrative clinical notes using natural language processing
2017
Knowledge translation of research findings
2012 Standout
Urinary Tract Infection Syndromes
2013 Standout
Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations
2011
All-Cause Readmission and Repeat Revascularization After Percutaneous Coronary Intervention in a Cohort of Medicare Patients
2009
An overview of the antimicrobial resistance mechanisms of bacteria
2018
Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation
2017
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update
2014
Interventions to improve hand hygiene compliance in patient care
2017 Standout
Plazomicin: A Next‐Generation Aminoglycoside
2018
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution
2012
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
Impact of a Renal Drug Dosing Service on Dose Adjustment in Hospitalized Patients with Chronic Kidney Disease
2009
Novel Carbapenem Antibiotics for Parenteral and Oral Applications: In Vitro and In Vivo Activities of 2-Aryl Carbapenems and Their Pharmacokinetics in Laboratory Animals
2012
Variability in Antibiotic Use Across Nursing Homes and the Risk of Antibiotic-Related Adverse Outcomes for Individual Residents
2015
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Bacterial Antibiotic Resistance: The Most Critical Pathogens
2021 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Multistate Point-Prevalence Survey of Health Care–Associated Infections
2014 Standout
In Vitro Activities of LTX-109, a Synthetic Antimicrobial Peptide, against Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, Daptomycin-Nonsusceptible, and Linezolid-Nonsusceptible Staphylococcus aureus
2012
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Decreasing Clostridium difficile Infections by an Antimicrobial Stewardship Program That Reduces Moxifloxacin Use
2014
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of Michael Oinonen being referenced
Trends in Antibacterial Use in US Academic Health Centers
2008
How Do Academic Health Centers Value and Encourage Clinical Research?
2001
Clinical and Economic Outcomes of Coronary Angioplasty Alone or in Combination with Stents in Academic Health Centers: A Retrospective Database Analysis
2000
Trends in Aminoglycoside Use and Gentamicin-Resistant Gram-Negative Clinical Isolates in US Academic Medical Centers: Implications for Antimicrobial Stewardship
2012
Use of International Classification of Diseases, Ninth Revision Clinical Modification Codes and Medication Use Data to Identify Nosocomial Clostridium difficile Infection
2009
Trends in Antibacterial Use in Hospitalized Pediatric Patients in United States Academic Health Centers
2009
Economic Impact of Clostridium difficile Infection in a Multihospital Cohort of Academic Health Centers
2011
Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa
2009
Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital‐Onset C lostridium difficile Infection: Implications for Antimicrobial Stewardship
2012
Potentially inappropriate medications in hospitalized senior patients
2006
Antifungal use in hospitalized adults in U.S. academic health centers
2011